| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | ABBOTT REALTIME HCV GENOTYPE II, ABBOTT REALTIME HCV GENOTYPE II CONTROL KIT, URACIL-N-GLYCOSYLASE (UNG) |
| Generic Name | Assay, genotyping, hepatitis c virus |
| Regulation Number | 866.3170 |
| Applicant | Abbott Molecular 1300 E Touhy Ave. Des Plaines, IL 60018 |
| PMA Number | P120012 |
| Supplement Number | S012 |
| Date Received | 03/28/2016 |
| Decision Date | 04/12/2016 |
| Reclassified Date | 12/22/2021 |
| Product Code |
OBF |
| Advisory Committee |
Microbiology |
| Supplement Type | 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Change to consolidate the current QC testing for the Amplification Reagent Kit from two stages into a single finished kit QC stage. |
|
|